Maternal vaccinations coverage and reasons for non-compliance - a cross-sectional observational study.
Adult
Cross-Sectional Studies
Female
Humans
Influenza Vaccines
Influenza, Human
/ prevention & control
Maternal Behavior
Patient Compliance
/ statistics & numerical data
Pertussis Vaccine
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Self Report
Vaccination Coverage
/ statistics & numerical data
Whooping Cough
/ prevention & control
Young Adult
Compliance
Influenza
Pertussis
Pregnancy
Vaccine
Journal
BMC pregnancy and childbirth
ISSN: 1471-2393
Titre abrégé: BMC Pregnancy Childbirth
Pays: England
ID NLM: 100967799
Informations de publication
Date de publication:
16 Sep 2020
16 Sep 2020
Historique:
received:
10
07
2020
accepted:
09
09
2020
entrez:
17
9
2020
pubmed:
18
9
2020
medline:
8
6
2021
Statut:
epublish
Résumé
Maternal influenza and pertussis vaccinations have been proven safe and effective in reducing maternal and infant morbidity and mortality. Though recommended, not all pregnant women receive these important vaccines. We aimed to evaluate the vaccine coverage of maternal immunization in pregnancy for seasonal influenza and acellular pertussis and elucidate the reasons for non-vaccination among pregnant women. The secondary objective was to describe factors that affect vaccine uptake. A cross sectional observational study using anonymous questionnaires distributed to women in the maternity ward or pregnant women hospitalized in the high-risk ward, between Nov 2017 and June 2018, In an Israeli tertiary hospital. Of 321 women approached, 313 were eligible, with a total of 290 women completing the questionnaire (92.6%). We found a 75.9% (95% CI 71-81) and 34.5% (95% CI 29-40) vaccination rate for pertussis and influenza vaccines, respectively. The most prominent reason for not receiving the pertussis vaccine was being under-informed (24%). Influenza vaccine was not received mainly due to concerns about vaccine efficacy (28%). Other factors influencing vaccine uptake included education, prior childbirth and vaccine recommendations made by the provider. Although maternal vaccination of pertussis and influenza is officially recommended, vaccine uptake is suboptimal. Our study suggests a central role for medical providers in diminishing the concerns about safety and efficacy, and presents novel factors influencing compliance rates, like seasonality and number of prior births.
Sections du résumé
BACKGROUND
BACKGROUND
Maternal influenza and pertussis vaccinations have been proven safe and effective in reducing maternal and infant morbidity and mortality. Though recommended, not all pregnant women receive these important vaccines. We aimed to evaluate the vaccine coverage of maternal immunization in pregnancy for seasonal influenza and acellular pertussis and elucidate the reasons for non-vaccination among pregnant women. The secondary objective was to describe factors that affect vaccine uptake.
METHODS
METHODS
A cross sectional observational study using anonymous questionnaires distributed to women in the maternity ward or pregnant women hospitalized in the high-risk ward, between Nov 2017 and June 2018, In an Israeli tertiary hospital.
RESULTS
RESULTS
Of 321 women approached, 313 were eligible, with a total of 290 women completing the questionnaire (92.6%). We found a 75.9% (95% CI 71-81) and 34.5% (95% CI 29-40) vaccination rate for pertussis and influenza vaccines, respectively. The most prominent reason for not receiving the pertussis vaccine was being under-informed (24%). Influenza vaccine was not received mainly due to concerns about vaccine efficacy (28%). Other factors influencing vaccine uptake included education, prior childbirth and vaccine recommendations made by the provider.
CONCLUSION
CONCLUSIONS
Although maternal vaccination of pertussis and influenza is officially recommended, vaccine uptake is suboptimal. Our study suggests a central role for medical providers in diminishing the concerns about safety and efficacy, and presents novel factors influencing compliance rates, like seasonality and number of prior births.
Identifiants
pubmed: 32938428
doi: 10.1186/s12884-020-03243-w
pii: 10.1186/s12884-020-03243-w
pmc: PMC7493363
doi:
Substances chimiques
Influenza Vaccines
0
Pertussis Vaccine
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
541Références
Vaccine. 2015 Feb 18;33(8):1056-62
pubmed: 25573035
Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S141-8
pubmed: 21492825
Euro Surveill. 2015 Feb 12;20(6):
pubmed: 25695476
CMAJ. 2014 Mar 4;186(4):E157-64
pubmed: 24396098
Vaccine. 2016 Nov 11;34(47):5785-5791
pubmed: 27742214
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S38-46
pubmed: 22920058
West J Nurs Res. 2017 Oct;39(10):1366-1367
pubmed: 28906202
Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S3-8
pubmed: 22920056
JAMA. 2014 May 7;311(17):1760-9
pubmed: 24794369
Lancet. 2014 Oct 25;384(9953):1521-8
pubmed: 25037990
Isr Med Assoc J. 2006 May;8(5):308-11
pubmed: 16805226
Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):334-41
pubmed: 22486173
Vaccine. 2014 Aug 6;32(36):4602-13
pubmed: 24996123
Pediatr Crit Care Med. 2016 Aug;17(8):735-42
pubmed: 27362854
MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1055-1059
pubmed: 30260946
Clin Infect Dis. 2010 Dec 15;51(12):1355-61
pubmed: 21058908
Emerg Infect Dis. 2008 Jan;14(1):95-100
pubmed: 18258087